Long-term clinical trials of biologics in plaque psoriasis demonstrate heterogeneous study designs

Br J Dermatol. 2023 Apr 20;188(5):677-678. doi: 10.1093/bjd/ljac142.

Authors

Chloé Grolleau^{1

2}, Laurence Le Cleach^{1

2}, Jason Shourick^{1

2}, Emilie Sbidian^{1

2

3}, Sivem Afach²

Affiliations

¹ AP-HP, Hôpitaux universitaires Henri Mondor, Département de Dermatologie, UPEC, Créteil, F-94010, France.
² Université Paris-Est Créteil, UPEC, EpiDermE EA 7379, Créteil, F-94010, France.
³ INSERM, Centre d'Investigation Clinique 1430, Créteil, F-94010, France.

PMID: 36702800
DOI: 10.1093/bjd/ljac142

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use
Biological Products* / therapeutic use
Humans
Psoriasis* / drug therapy
Research Design
Treatment Outcome

Substances

Biological Products
Antibodies, Monoclonal